Purchase Order 36C26226P0733
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 16 awarded a $1.85 million firm fixed-price purchase order to Cepheid Inc. for test kits and consumables on January 30, 2026, with an ultimate completion date of January 29, 2031. This contract delivers molecular diagnostic reagents and test kits for the Cepheid GeneXpert diagnostic platform, including consumables for detecting SARS-CoV-2, influenza, respiratory syncytial virus, Streptococcus A, Chlamydia...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a delivery order valued at $332,628.00 for Cepheid GeneXpert reagents and supplies. The contract, issued on April 1, 2026, operates under a firm fixed-price structure with no set-aside designation and is scheduled for completion by September 30, 2026. This delivery order derives from Cepheid's extensive Indefinite Delivery...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a firm fixed-price purchase order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, with a ceiling value of $1.2M and a completion date of September 30, 2030. This contract covers Cepheid reagents and related molecular diagnostic testing solutions. The award carries no set-aside designation and reflects VISN 16's ongoing procurement of advanced diagnostic...
- The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21) awarded a delivery order valued at $172,455.68 to Cepheid Inc. on October 1, 2024, for Cepheid GeneXpert test systems utilizing a cost-per-test (CPT) and cost-per-reportable-result (CPRR) pricing model. The contract is structured as a firm fixed-price delivery order with no set-aside designation and will be completed by September 30, 2029. Services will be performed at Cepheid's facility in Sunnyvale,...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a purchase order valued at $5.17 million by the Department of Veterans Affairs' Veterans Integrated Service Network 8 on October 1, 2022. This firm fixed-price contract, with no set-aside designation, is a modification to an existing agreement that adjusts clinical quantities based on updated workload estimates for microbiology testing services. The contract calls for an all-inclusive...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a $613,093.80 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) for Cepheid reagents. The contract was awarded on March 1, 2026, with an ultimate completion date of February 28, 2027, and carries no set-aside designation. As a leading supplier of molecular diagnostic solutions to the federal healthcare system, Cepheid will deliver diagnostic reagents and...
- Cepheid Inc. was awarded a $306,000 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) on October 1, 2025, for the supply of Cepheid testing kits. The contract carries an ultimate completion date of March 31, 2026, with no set-aside designation. As a molecular diagnostics manufacturer headquartered in Sunnyvale, California, Cepheid supplies the federal healthcare system with advanced diagnostic solutions, particularly its...
- On December 22, 2025, the Department of Veterans Affairs' Veterans Integrated Service Network 17 (VISN 17) awarded a $1.56M delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents. This delivery order, representing the first ordering period under a larger single-award Indefinite Delivery Contract (IDC) valued at $6.74M through December 28, 2029, procures diagnostic reagents and test kits designed for Cepheid's GeneXpert diagnostic...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 20 awarded a firm fixed-price blanket purchase agreement (BPA) call to Cepheid Inc. for COVID-19 test kits valued at $199,986.50. The contract runs from September 1, 2025, through August 31, 2026, with no set-aside designation. The award represents a delivery order under Cepheid's existing BPA vehicle with VISN 20, supporting diagnostic testing capabilities across the VA's healthcare network in the western region....
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order by the Department of Veterans Affairs (Veterans Integrated Service Network 21) on October 1, 2024, for GeneXpert test kits valued at $505,664.35. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, will be performed in San Francisco, California. No set-aside designation was used for this procurement. This award represents a...
The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22) awarded a firm fixed-price purchase order valued at $1.98 million to Cepheid Inc. on March 31, 2026, for the supply of COVID-19 reagents and molecular diagnostic test supplies. The contract, which extends through September 30, 2026, fulfills a solicitation issued in early March 2026 for Cepheid GeneXpert-compatible diagnostic kits and consumables to support eight VA healthcare facilities across California, Arizona, and New Mexico. Deliverables include approximately 5,020 units of various diagnostic test kits, including assays for COVID-19, influenza, respiratory syncytial virus, and other infectious diseases, along with comprehensive service and maintenance coverage for 11 GeneXpert molecular diagnostic systems at the specified VA facilities. The contract includes Monday-through-Friday service visits, 24/7 phone support, preventive maintenance, and emergency repairs with 24-hour response times, with all supplies delivered on a cost-per-test basis and all shipping costs included. This award continues Cepheid's established role as a primary federal supplier of molecular diagnostic solutions to the VA healthcare system. The company, headquartered in Sunnyvale, California, has demonstrated significant federal contracting capacity through multiple indefinite delivery contracts with various VA Veterans Integrated Service Networks, including a $32.8 million contract with VISN 6 and a $6.7 million contract with VISN 17, both extending through 2029–2030. The VISN 22 purchase order was awarded through full and open competition with no set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics procurement market and supporting the VA's clinical laboratory operations and infectious disease testing capabilities across its distributed network of medical centers.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6550--Reagents | 36C26226Q0433 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 | Award Notice 2/2 | 4/1/26, 5:30 PM | |
6550--Covid Reagents and Supplies | 36C26226Q0433 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 | Solicitation 1/2 | 3/3/26, 5:44 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0m | 3/30/26 |